Skip to main content
Premium Trial:

Request an Annual Quote

Cellumen Will Profile Environmental Chemicals for Toxins for EPA's Toxcast Program

NEW YORK (GenomeWeb News) — Cellumen will profile potentially toxic compounds for an Environmental Protection Agency program, the company said today.
 
Under the multi-year agreement with EPA’s Toxcast program, Cellumen said it will use its cytotoxicity profiling method to test chemicals that may be harmful to humans.
 
Toxcast aims to “better prioritize environmental chemicals while reducing costs and dependency on animal testing,” Kate Johnston, Cellumen’s vice president of Discovery Programs, said in a statement.
 
Cellumen said its profiling technique measures full-dose responses for 11 cellular parameters at three points, and produces 330 data points per compound.
 
Financial terms of the agreement were not disclosed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.